Solid Biosciences Stock Options
| SLDB Stock | USD 5.09 0.06 1.17% |
Solid Biosciences' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 1.53 with a put-to-call open interest ratio of 1.27 over 10 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on June 20th 2025. The total put volume is at 1.0, with calls trading at the volume of 1.0. This yields a 1.0 put-to-call volume ratio.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows Solid Biosciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Solid Biosciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Solid Biosciences' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Solid Biosciences
Analyzing Solid Biosciences' in-the-money options over time can help investors to take a profitable long position in Solid Biosciences regardless of its overall volatility. This is especially true when Solid Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Solid Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Solid Biosciences' stock while costing only a fraction of its price.
Solid Biosciences' stock options are financial instruments that give investors the right to buy or sell shares of Solid Biosciences LLC common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Solid stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Solid Biosciences' stock price goes up or down, the stock options follow.
At present, Solid Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 41.4 K, whereas Total Stockholder Equity is forecasted to decline to about 89.1 M. Solid Biosciences LLC In The Money Call Balance
When Solid Biosciences' strike price is surpassing the current stock price, the option contract against Solid Biosciences LLC stock is said to be in the money. When it comes to buying Solid Biosciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Solid Biosciences LLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Solid Current Options Market Mood
Solid Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Solid Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Solid Biosciences' options investors are not very successful. Solid Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Solid contract
Base on the Rule 16, the options market is currently suggesting that Solid Biosciences LLC will have an average daily up or down price movement of about 0.0956% per day over the life of the 2025-06-20 option contract. With Solid Biosciences trading at USD 5.09, that is roughly USD 0.004867. If you think that the market is fully incorporating Solid Biosciences' daily price movement you should consider buying Solid Biosciences LLC options at the current volatility level of 1.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Solid |
Purchasing Solid Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Solid calls. Remember, the seller must deliver Solid Biosciences LLC stock to the call owner when a call is exercised.
Solid Biosciences Option Chain
When Solid Biosciences' strike price is surpassing the current stock price, the option contract against Solid Biosciences LLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Solid Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Solid. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Solid. It also shows strike prices and maturity days for a Solid Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | SLDB250620C00012500 | 5 | 12.5 | 0.0 - 2.75 | 0.18 | Out |
Call | SLDB250620C00010000 | 97 | 10.0 | 0.0 - 2.7 | 0.36 | Out |
Call | SLDB250620C00007500 | 258 | 7.5 | 0.0 - 2.05 | 0.72 | Out |
Call | SLDB250620C00005000 | 561 | 5.0 | 0.65 - 1.3 | 0.91 | In |
Call | SLDB250620C00002500 | 74 | 2.5 | 0.75 - 3.9 | 2.7 | In |
Put | SLDB250620P00012500 | 0 | 12.5 | 5.8 - 7.9 | 5.8 | In |
Put | SLDB250620P00010000 | 0 | 10.0 | 3.8 - 7.5 | 3.8 | In |
Put | SLDB250620P00007500 | 22 | 7.5 | 2.4 - 4.5 | 2.87 | In |
Put | SLDB250620P00005000 | 191 | 5.0 | 0.75 - 1.3 | 0.75 | Out |
Put | SLDB250620P00002500 | 1055 | 2.5 | 0.0 - 0.1 | 0.05 | Out |
Solid Total Stockholder Equity
Total Stockholder Equity |
|
Solid Biosciences Corporate Executives
Elected by the shareholders, the Solid Biosciences' board of directors comprises two types of representatives: Solid Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Solid. The board's role is to monitor Solid Biosciences' management team and ensure that shareholders' interests are well served. Solid Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Solid Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.